Discovery of the Novel HLA-DRB3*01:01:25 Allele Using PacBio Sequencing
Wenqian Song1, Wanzhen Yu2, Suning Bai2
1Dalian Blood Center, Dalian, Liaoning, China.
HLA
|April 30, 2026
Summary
Human Leukocyte Antigen (HLA) -DRB3*01:01:25 has a single nucleotide substitution in exon 2 and intronic alterations compared to DRB3*01:01:02:08. These genetic variations are important for understanding HLA allele diversity.
Area of Science:
- Immunogenetics
- Molecular biology
Background:
- Human Leukocyte Antigen (HLA) genes are crucial for immune response.
- Specific HLA alleles, such as HLA-DRB3, play a significant role in immune system function and disease susceptibility.
Purpose of the Study:
- To characterize the genetic differences between two closely related HLA-DRB3 alleles: HLA-DRB3*01:01:25 and HLA-DRB3*01:01:02:08.
- To identify specific nucleotide substitutions and intronic variations that distinguish these alleles.
Main Methods:
- DNA sequencing of the relevant HLA-DRB3 gene regions.
- Bioinformatic analysis to compare nucleotide sequences and identify variations.
Main Results:
- HLA-DRB3*01:01:25 differs from HLA-DRB3*01:01:02:08 by a single nucleotide substitution located in exon 2.
- Additional intronic sequence variations were identified between the two alleles.
Conclusions:
- The identified genetic variations contribute to the allelic diversity within the HLA-DRB3 locus.
- Understanding these specific differences is essential for accurate HLA typing and immunological studies.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
01:05Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121